Accretion Pharmaceuticals Limited Share Price & Stock Analysis

Accretion Pharmaceuticals Limited (NSE: ACCPL) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹226 Cr, it ranks #2,547 by market cap among the 6,197 Indian listed companies on FinBizNet, and #35 of 63 in Pharmaceuticals.

Key Metrics

Current Price₹213.90
Market Cap₹226 Cr
NSE SymbolACCPL
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio23.7
Return on Equity27.63%
Return on Assets14.85%
Beta (1Y)0.27
HeadquartersAhmedabad, Gujarat
Websitewww.accretionpharma.com

Shareholding and Delivery

Promoters held 73.52% of Accretion Pharmaceuticals Limited's shares as of Sept 2026, unchanged from Sept 2025.

About Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited engages in the manufacturing and marketing of pharmaceutical products in India. The company offers antibiotic, antibacterial, antifungal, anti-inflammatory, anti-spasmodic, antihistamine, antiallergy, anticough, anticold, antiulcer, gastrointestinal, antacid, anti-diabetic, cardiac, anti-hypertensive, psychotropic, memory enhancer, vitamins, supplements, and other products. It also provides external preparation, oral powder, effervescent formulation, and nutraceutical products, as well as formulations for brain and memory care, neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, GIT care, joint and bone care, immunity booster, gynec care, hair and skin care, nail care, and infertility, and PCOS care. The company offers its products in the form of tablets, capsules, oral liquid, ointment, cream, gel, lotion, medicated shampoo, mouthwash, dusting powder, sachet, and dry syrup through contract manufacturing and direct sale

Products and Services

1. Manufacturing and Sale of Pharmaceutical Products-This segment engages in the manufacturing and sale of tablets, capsules, oral liquids, external preparations, oral powders, etc. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Manufacturing and Sale of Pharmaceutical Products-100%

Accretion Pharmaceuticals Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Accretion Pharmaceuticals Limited₹226 Cr23.727.63%——

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Accretion Pharmaceuticals Limited?

Accretion Pharmaceuticals Limited is trading at ₹213.90, with a market capitalisation of ₹226 Cr.

Which sector does Accretion Pharmaceuticals Limited belong to?

Accretion Pharmaceuticals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Accretion Pharmaceuticals Limited?

Accretion Pharmaceuticals Limited has a P/E of 23.7 and a return on equity of 27.63%.

What is the stock symbol of Accretion Pharmaceuticals Limited?

Accretion Pharmaceuticals Limited is listed on the NSE under the symbol ACCPL.

What is the promoter holding in Accretion Pharmaceuticals Limited?

Promoters held 73.52% of Accretion Pharmaceuticals Limited's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.